These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 19160220)
61. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center. Kim JW; Kim I; Oh KH; Yoon SS; Oh MD; Song YW; Heo DS; Bang YJ; Han KS; Han JS; Park S; Kim BK Hematology; 2011 Mar; 16(2):73-9. PubMed ID: 21418736 [TBL] [Abstract][Full Text] [Related]
62. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. George JN; Li X; McMinn JR; Terrell DR; Vesely SK; Selby GB Transfusion; 2004 Feb; 44(2):294-304. PubMed ID: 14962323 [TBL] [Abstract][Full Text] [Related]
63. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange. Clark WF Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967 [TBL] [Abstract][Full Text] [Related]
64. Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Bittencourt CE; Ha JP; Maitta RW PLoS One; 2015; 10(5):e0127744. PubMed ID: 26000799 [TBL] [Abstract][Full Text] [Related]
65. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other? Shibagaki Y; Fujita T Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259 [TBL] [Abstract][Full Text] [Related]
66. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation. Sarode R; McFarland JG; Flomenberg N; Casper JT; Cohen EP; Drobyski WR; Ash RC; Horowitz MM; Camitta B; Lawton C Bone Marrow Transplant; 1995 Aug; 16(2):271-5. PubMed ID: 7581147 [TBL] [Abstract][Full Text] [Related]
67. Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli. Nakayama S; Hirashio S; Yorishima H; Doi T; Yoshida Y; Matsumoto M; Masaki T CEN Case Rep; 2019 Nov; 8(4):266-270. PubMed ID: 31177384 [TBL] [Abstract][Full Text] [Related]
68. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease. Furlan M; Lämmle B Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108 [TBL] [Abstract][Full Text] [Related]
69. Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome. Rizvi MA; Vesely SK; George JN; Chandler L; Duvall D; Smith JW; Gilcher RO Transfusion; 2000 Aug; 40(8):896-901. PubMed ID: 10960513 [TBL] [Abstract][Full Text] [Related]
75. Immunosuppressive agents for treating IgA nephropathy. Vecchio M; Bonerba B; Palmer SC; Craig JC; Ruospo M; Samuels JA; Molony DA; Schena FP; Strippoli GF Cochrane Database Syst Rev; 2015 Aug; (8):CD003965. PubMed ID: 26235292 [TBL] [Abstract][Full Text] [Related]
76. [Familial, recurring plasma infusion dependent thrombotic thrombocytopenic purpura/hemolytic uremic syndrome]. Litwin M; Smirska E Pol Merkur Lekarski; 2000 Apr; 8(46):289-90. PubMed ID: 10897656 [TBL] [Abstract][Full Text] [Related]
77. Syndromes of Thrombotic Microangiopathy. Shatzel JJ; Taylor JA Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178 [TBL] [Abstract][Full Text] [Related]